A Study of ALS-008176 in Infants Hospitalized With RSV

NCT02202356 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

DRUG: ALS-008176
DRUG: Placebo

Sponsor

Alios Biopharma Inc.